ICD-10 Coding for Mesenteric Mass(D20.3, D20.3B, D20.3N)
Learn about ICD-10 coding for mesenteric masses, including neuroendocrine and benign tumors. Find documentation requirements and coding tips.
Complete code families applicable to Mesenteric Mass
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C7A.092 | Malignant neuroendocrine tumor of the mesentery | Use when pathology confirms a mesenteric neuroendocrine tumor. |
|
| D20.3 | Benign neoplasm of mesothelial tissue | Use when biopsy confirms a benign mesenteric tumor. |
|
| R19.0 | Intra-abdominal and pelvic swelling, mass and lump | Use for unspecified masses when further investigation is needed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMesenteric Mass
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Mesenteric Mass.
Non-specific documentation of mass
Impact
Clinical: May lead to misdiagnosis, Regulatory: Fails to meet documentation standards, Financial: Potential loss of reimbursement
Mitigation
Ensure detailed imaging and pathology reports., Use specific terminology.
Using R19.0 for confirmed neoplasms
Impact
Reimbursement: Potential underpayment due to non-specific coding, Compliance: Non-compliance with coding guidelines, Data Quality: Decreased accuracy in medical records
Mitigation
Use specific neoplasm codes like C7A.092 or D20.3 when diagnosis is confirmed.
Neoplasm coding
Impact
Risk of incorrect coding due to non-specific documentation.
Mitigation
Ensure pathology confirmation and detailed documentation.
Frequently Asked Questions
Primary Code
Malignant neuroendocrine tumor of the mesenteryC7A.092Benign neoplasm of mesothelial tissueon-